GSK plc Files Director Shareholding Report
Ticker: GSK · Form: 6-K · Filed: 2026-04-10T11:54:04-04:00
Sentiment: neutral
Topics: insider-filing, director-shareholding, 6-K
TL;DR
GSK insiders bought/sold shares, check a0489a.htm for details.
AI Summary
On April 10, 2026, GSK plc filed a Form 6-K, reporting a Director/PDMR Shareholding. The filing details share transactions by individuals who are directors or Persons Discharging Managerial Responsibility within the company. Specific details regarding the number of shares, transaction dates, and prices are contained within the attached document a0489a.htm.
Why It Matters
This filing provides transparency into insider transactions, which can offer insights into the confidence executives have in the company's future performance.
Risk Assessment
Risk Level: low — This is a routine disclosure of director and PDMR shareholdings, not indicative of significant company-specific risk.
Key Players & Entities
- GSK plc (company) — Filer of the report
- a0489a.htm (document) — Attached document detailing shareholding
FAQ
What type of filing is this?
This is a Form 6-K, a Report of foreign issuer.
What is the primary purpose of this filing?
The filing reports Director/PDMR Shareholding information.
When was this filing accepted by the SEC?
The filing was accepted on April 10, 2026, at 11:54:04.
What is the CIK number for GSK plc?
The CIK number for GSK plc is 0001131399.
Where is GSK plc's mailing and business address listed?
GSK plc's mailing and business address is listed as 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG.
From the Filing
EDGAR Filing Documents for 0001654954-26-003401 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001654954-26-003401 Filing Date 2026-04-10 Accepted 2026-04-10 11:54:04 Documents 1 Period of Report 2026-04-10 Document Format Files Seq Description Document Type Size 1 DIRECTOR/PDMR SHAREHOLDING a0489a.htm 6-K 268124 Complete submission text file 0001654954-26-003401.txt 269379 Mailing Address 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG Business Address 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG 44 20 8047 5000 GSK plc (Filer) CIK : 0001131399 (see all company filings) EIN. : 000000000 | State of Incorp.: X0 Type: 6-K | Act: 34 | File No.: 001-15170 | Film No.: 26853830 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)